Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

A bill filed in Springfield would allow doctors to prescribe some HIV medication without needing prior authorization.

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...